Online Program Home
My Program

CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Activity Details

140 * ! Mon, 7/30/2018, 10:30 AM - 12:20 PM CC-West 211
Design and Analysis of Cancer Immunotherapy Trials — Invited Papers
Biopharmaceutical Section, Society for Clinical Trials, Statistics in Biopharmaceutical Research Journal
Organizer(s): Zhenzhen Xu , FDA
Chair(s): Bifeng Ding, AbbVie
10:35 AM A Bayesian Phase I/II Trial Design for Immunotherapy

Suyu Liu, MD Anderson Cancer Center; Beibei Guo, Louisiana State University; Ying Yuan, University of Texas M.D. Anderson Cancer Center
11:00 AM Achieving Optimal Power of Logrank Test with Random Treatment Time-Lag Effect
Zhenzhen Xu , FDA; Yongsoek Park, Unversity of Pittsburgh; Boguang Zhen, FDA; Bin Zhu, NIH/NCI
11:25 AM Use of Piecewise Weighted Log-Rank Test for Trials with Delayed Treatment Effect

Boguang Zhen, FDA; Zhenzhen Xu , FDA; Bin Zhu, NIH/NCI; Yongsoek Park, Unversity of Pittsburgh
11:50 AM Practical Considerations on the Challenges to the Design and Analysis of Immuno-Oncology Trials

Yabing Mai, AbbVie, Inc; Yue Shentu, Merck and Co Inc
12:15 PM Floor Discussion